Aortic coarctation itself is a high-risk disease, divided into type A and type B. Among them, the mortality rate of surgery for type A coarctation is about 10%-30%, while type B coarctation is mostly treated by endoluminal treatment, i.e. interventional treatment, through a small incision in the femoral artery, stents are put into the aorta for endoluminal isolation, and the mortality rate of this procedure is lower, basically within 5%. However, if the patients themselves have combined diseases or complications, such as involvement of the nervous system, digestive system, and cerebral ischemia, cerebral infarction, and superior mesenteric artery ischemia, etc., the mortality rate and treatment outcome of the procedure can be affected.